ACE and obesity disorder: Adults prescribed oxybutynin were more likely to have a diagnosis of hypertension or obesity and to have filled a prescription for a diuretic, angiotensin-converting enzyme (ACE) inhibitor, or an older generation antihypertensive in the preceding 180 days (S1B Appendix).